Related Experiment Video

Updated: May 21, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

The Charlson comorbidity index as a predictor of outcomes in liver transplantation: single-center experience

G Grosso1, F di Francesco, G Vizzini

  • 1GF Ingrassia Institute, University of Catania, Catania, Italy.

Transplantation Proceedings
|June 6, 2012
PubMed

Insights

The Charlson comorbidity index (CCI) effectively predicts outcomes after liver transplantation. Higher CCI scores are linked to reduced patient survival and increased graft loss, highlighting its value in patient management.

Area of Science:

  • Hepatology
  • Transplantation Surgery
  • Medical Statistics

Background:

  • Liver transplantation requires accurate prognostic tools to manage organ allocation and predict patient outcomes.
  • Existing comorbidity indices like CTP and MELD have limitations in predicting post-transplant success.
  • The Charlson comorbidity index (CCI) has shown promise but requires further validation in liver transplant recipients.

Purpose of the Study:

  • To evaluate the efficacy of the Charlson comorbidity index (CCI) in predicting patient survival and graft survival after liver transplantation.
  • To determine if preoperative comorbidity, as assessed by the CCI, impacts post-transplant outcomes.
  • To assess the utility of the CCI as a tool for patient management in liver transplant candidates.

Main Methods:

  • Retrospective review of data from 221 liver transplant recipients.
  • Inclusion of living-related and multiple organ transplantations between January 2006 and September 2009.
  • Survival analysis, including Kaplan-Meier plots and log-rank tests, to assess the association between CCI and outcomes.

Main Results:

  • A significant association was found between higher CCI scores and decreased post-transplantation patient survival (P = .003).
  • The CCI demonstrated a significant association with graft survival, with higher scores correlating to reduced graft survival (P = .039).
  • Preoperative patient comorbidity, measured by CCI, was identified as a risk factor for graft loss and patient mortality.

Conclusions:

  • The Charlson comorbidity index (CCI) is a simple and effective tool for evaluating comorbidity in liver transplant candidates.
  • Increased preoperative comorbidity, indicated by a higher CCI, significantly increases the risk of graft loss and patient death post-transplantation.
  • The CCI should be considered a valuable tool for improving patient care and management strategies in liver transplantation.

More Related Videos

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation08:39

Reduced Complications after Arterial Reconnection in a Rat Model of Orthotopic Liver Transplantation

Published on: November 7, 2020

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...